Veterinary Vaccines Market 2026: Latest Approvals, Innovations & Industry Trends Dashboard
The global veterinary vaccines market has reached a remarkable milestone in 2026, valued at $16.04 billion and projected to grow at an impressive 6.99% CAGR to reach $24.15 billion by 2032. This unprecedented growth is fueled by groundbreaking innovations including Elanco’s newly approved TruCan Ultra CIV canine influenza vaccine and Befrena (tirnovetmab) for allergic dermatitis,… Read More »